The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models
Yunrong Zhu(Southeast University), Yunqing Zhang(Jiangyin People's Hospital)
Cited by 47
Related Papers
PF-06409577 Activates AMPK Signaling and Inhibits Osteosarcoma Cell Growth
|Frontiers in Oncology|2021|13